A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma

Published:2024-07 Issue:7 Volume:14 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

DeStefano Vincent M¹^ORCID,Wada Masayuki¹,Pinz Kevin G¹,Assi Rita²,Zhang Hongyu³,Wang Weijia⁴,Zhang Wenli³,Shah Darshi¹,Ma Yupo¹,Salman Huda⁵

Affiliation:

1. Research & Development Division iCell Gene Therapeutics Inc., Long Island High Technology Incubator Stony Brook New York USA

2. Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA

3. Department of Hematology Peking University Shenzhen Hospital Shenzhen China

4. Department of Advanced Diagnostic and Clinical Medicine Zhongshan People's Hospital Zhongshan People's Republic of China

5. Brown Center for Immunotherapy Indiana University School of Medicine Indianapolis Indiana USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1743

Reference10 articles.

1. Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy

2. Engineering strategies to overcome the current roadblocks in CAR T cell therapy

3. Bispecific antibodies in oncology

4. B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies

5. CD19: a biomarker for B cell development, lymphoma diagnosis and therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP